HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
374.90
+13.58 (3.76%)
At close: Jun 9, 2026, 4:00 PM EDT
375.00
+0.10 (0.03%)
Pre-market: Jun 10, 2026, 5:44 AM EDT

HCA Healthcare Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $506.67. The average 1-year stock price forecast is 35.15% higher than the current stock price, while the lowest is $396 (+5.63%) and the highest is $635 (+69.38%).

Price Target: $506.67 (+35.15%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$396$506.67$510$635
Change+5.63%+35.15%+36.04%+69.38%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy131313131313
Buy222222
Hold889999
Sell110000
Strong Sell111111
Total252525252525

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Maintains
$503$413
HoldMaintains$503$413+10.16%Jun 4, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 28, 2026
TD Cowen
TD Cowen
Buy
Maintains
$392$500
BuyMaintains$392$500+33.37%May 27, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$490
HoldMaintains$490+30.70%May 23, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$540$480
HoldMaintains$540$480+28.03%Apr 27, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
78.56B
from 75.60B
Increased by 3.92%
Revenue Next Year
82.35B
from 78.56B
Increased by 4.82%
EPS This Year
30.14
from 28.21
Increased by 6.85%
EPS Next Year
33.11
from 30.14
Increased by 9.83%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
58.75B60.23B64.97B70.60B75.60B78.56B
Revenue Growth
14.01%2.52%7.86%8.67%7.08%3.92%
Gross Profit
22.49B23.18B25.58B28.68B31.37B32.53B
Gross Margin
38.28%38.48%39.37%40.62%41.50%41.40%
Operating Income
9.68B9.05B9.63B10.55B11.97B12.22B
Net Income
6.96B5.64B5.24B5.76B6.78B6.74B
EPS
----28.2130.14
EPS Growth
----28.46%6.85%
Forward PE
14.1113.4514.2512.6015.9012.44
Dividend / Share
1.922.242.402.642.883.10
Dividend Growth
-16.67%7.14%10.00%9.09%7.68%
Free Cash Flow
4.08B3.08B2.87B3.92B5.82B7.75B
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High79.7B
Avg78.6B
Low77.0B

Revenue Growth

Revenue Growth202620272028
High
5.4%
Avg
3.9%
Low
1.9%

EPS Forecast

EPS202620272028
High30.90
Avg30.14
Low29.10

EPS Growth

EPS Growth202620272028
High
9.5%
Avg
6.9%
Low
3.2%